Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1989 Jun;44(6):491–495. doi: 10.1136/thx.44.6.491

Effect of inhaled leukotriene B4 alone and in combination with prostaglandin D2 on bronchial responsiveness to histamine in normal subjects.

P N Black 1, R W Fuller 1, G W Taylor 1, P J Barnes 1, C T Dollery 1
PMCID: PMC1020810  PMID: 2548300

Abstract

The effect of intradermal injection of leukotriene B4 alone and in combination with prostaglandin D2 and E2 and the effect of inhaled leukotriene B4 in combination with prostaglandin D2 were studied in six non-asthmatic men. The intradermal injection of leukotriene B4 (1 microgram) alone caused no immediate or late response in five of the six subjects but greatly potentiated the flare response to intradermal prostaglandin D2 (0.5 microgram) and E2 (0.5 microgram) in all subjects. In contrast, inhaled prostaglandin D2 (6 micrograms) alone and in combination with inhaled leukotriene B4 (12 micrograms) caused no change in the response to inhaled histamine, measured 30 minutes and three and six hours after the inhalation. These findings provide no support for the suggestion that leukotriene B4 has an important role in causing bronchial hyperresponsiveness. The possibility that higher doses of inhaled leukotriene B4 may alter bronchial responsiveness cannot, however, be ruled out.

Full text

PDF
491

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boushey H. A., Holtzman M. J., Sheller J. R., Nadel J. A. Bronchial hyperreactivity. Am Rev Respir Dis. 1980 Feb;121(2):389–413. doi: 10.1164/arrd.1980.121.2.389. [DOI] [PubMed] [Google Scholar]
  2. Cockcroft D. W., Murdock K. Y. Changes in bronchial responsiveness to histamine at intervals after allergen challenge. Thorax. 1987 Apr;42(4):302–308. doi: 10.1136/thx.42.4.302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cuss F. M., Dixon C. M., Barnes P. J. Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man. Lancet. 1986 Jul 26;2(8500):189–192. doi: 10.1016/s0140-6736(86)92489-x. [DOI] [PubMed] [Google Scholar]
  4. De Monchy J. G., Kauffman H. F., Venge P., Koëter G. H., Jansen H. M., Sluiter H. J., De Vries K. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis. 1985 Mar;131(3):373–376. doi: 10.1164/arrd.1985.131.3.373. [DOI] [PubMed] [Google Scholar]
  5. Ford-Hutchinson A. W., Bray M. A., Doig M. V., Shipley M. E., Smith M. J. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature. 1980 Jul 17;286(5770):264–265. doi: 10.1038/286264a0. [DOI] [PubMed] [Google Scholar]
  6. Fuller R. W., Dixon C. M., Dollery C. T., Barnes P. J. Prostaglandin D2 potentiates airway responsiveness to histamine and methacholine. Am Rev Respir Dis. 1986 Feb;133(2):252–254. doi: 10.1164/arrd.1986.133.2.252. [DOI] [PubMed] [Google Scholar]
  7. Fuller R. W., Morris P. K., Richmond R., Sykes D., Varndell I. M., Kemeny D. M., Cole P. J., Dollery C. T., MacDermot J. Immunoglobulin E-dependent stimulation of human alveolar macrophages: significance in type 1 hypersensitivity. Clin Exp Immunol. 1986 Aug;65(2):416–426. [PMC free article] [PubMed] [Google Scholar]
  8. MacIntyre N. R., Silver R. M., Miller C. W., Schuler F., Coleman R. E. Aerosol delivery in intubated, mechanically ventilated patients. Crit Care Med. 1985 Feb;13(2):81–84. doi: 10.1097/00003246-198502000-00005. [DOI] [PubMed] [Google Scholar]
  9. Murray J. J., Tonnel A. B., Brash A. R., Roberts L. J., 2nd, Gosset P., Workman R., Capron A., Oates J. A. Release of prostaglandin D2 into human airways during acute antigen challenge. N Engl J Med. 1986 Sep 25;315(13):800–804. doi: 10.1056/NEJM198609253151304. [DOI] [PubMed] [Google Scholar]
  10. O'Byrne P. M., Leikauf G. D., Aizawa H., Bethel R. A., Ueki I. F., Holtzman M. J., Nadel J. A. Leukotriene B4 induces airway hyperresponsiveness in dogs. J Appl Physiol (1985) 1985 Dec;59(6):1941–1946. doi: 10.1152/jappl.1985.59.6.1941. [DOI] [PubMed] [Google Scholar]
  11. PAZ R. A., SPECTOR W. G. The mononuclear-cell response to injury. J Pathol Bacteriol. 1962 Jul;84:85–103. doi: 10.1002/path.1700840111. [DOI] [PubMed] [Google Scholar]
  12. Peters S. P., MacGlashan D. W., Jr, Schulman E. S., Schleimer R. P., Hayes E. C., Rokach J., Adkinson N. F., Jr, Lichtenstein L. M. Arachidonic acid metabolism in purified human lung mast cells. J Immunol. 1984 Apr;132(4):1972–1979. [PubMed] [Google Scholar]
  13. Rollins T. E., Zanolari B., Springer M. S., Guindon Y., Zamboni R., Lau C. K., Rokach J. Synthetic leukotriene B4 is a potent chemotaxin but a weak secretagogue for human PMN. Prostaglandins. 1983 Feb;25(2):281–289. doi: 10.1016/0090-6980(83)90110-7. [DOI] [PubMed] [Google Scholar]
  14. Shaw R. J., Fitzharris P., Cromwell O., Wardlaw A. J., Kay A. B. Allergen-induced release of sulphidopeptide leukotrienes (SRS-A) and LTB4 in allergic rhinitis. Allergy. 1985 Jan;40(1):1–6. doi: 10.1111/j.1398-9995.1985.tb04147.x. [DOI] [PubMed] [Google Scholar]
  15. Soter N. A., Lewis R. A., Corey E. J., Austen K. F. Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4, and LTB4) in human skin. J Invest Dermatol. 1983 Feb;80(2):115–119. doi: 10.1111/1523-1747.ep12531738. [DOI] [PubMed] [Google Scholar]
  16. Wardlaw A. J., Dunnette S., Gleich G. J., Collins J. V., Kay A. B. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am Rev Respir Dis. 1988 Jan;137(1):62–69. doi: 10.1164/ajrccm/137.1.62. [DOI] [PubMed] [Google Scholar]
  17. Wardlaw A. J., Moqbel R., Cromwell O., Kay A. B. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. J Clin Invest. 1986 Dec;78(6):1701–1706. doi: 10.1172/JCI112765. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES